Stock Buzzer: DexCom, Inc. Has Another Very Weak Trading Session

Stock Buzzer: DexCom, Inc. Has Another Very Weak Trading Session

The stock of DexCom, Inc. (NASDAQ:DXCM) is a huge mover today! The stock decreased 3.06% or $2.68 during the last trading session, hitting $84.98. About 1.26M shares traded hands or 52.77% up from the average. DexCom, Inc. (NASDAQ:DXCM) has risen 29.44% since March 1, 2016 and is uptrending. It has outperformed by 17.23% the S&P500.
The move comes after 5 months negative chart setup for the $7.12B company. It was reported on Oct, 4 by We have $80.73 PT which if reached, will make NASDAQ:DXCM worth $356.00M less.

Analysts await DexCom, Inc. (NASDAQ:DXCM) to report earnings on November, 2. They expect $-0.13 EPS, down 85.71% or $0.06 from last year’s $-0.07 per share. After $-0.24 actual EPS reported by DexCom, Inc. for the previous quarter, Wall Street now forecasts -45.83% EPS growth.

DexCom, Inc. (NASDAQ:DXCM) Ratings Coverage

Out of 12 analysts covering Dexcom (NASDAQ:DXCM), 10 rate it a “Buy”, 0 “Sell”, while 2 “Hold”. This means 83% are positive. Dexcom has been the topic of 16 analyst reports since August 6, 2015 according to StockzIntelligence Inc. On Wednesday, February 24 the stock rating was maintained by Benchmark with “Buy”. On Wednesday, September 14 the stock rating was downgraded by BTIG Research to “Neutral”. Morgan Stanley initiated DexCom, Inc. (NASDAQ:DXCM) on Monday, November 2 with “Overweight” rating. The stock has “Neutral” rating given by Robert W. Baird on Monday, February 8. The company was upgraded on Thursday, October 15 by Sterne Agee CRT. The stock of DexCom, Inc. (NASDAQ:DXCM) earned “Overweight” rating by JP Morgan on Wednesday, February 24. The stock of DexCom, Inc. (NASDAQ:DXCM) earned “Outperform” rating by Leerink Swann on Thursday, October 15. Desjardins Securities upgraded the stock to “Buy” rating in Friday, September 16 report. The rating was maintained by JP Morgan with “Overweight” on Thursday, September 17. The stock of DexCom, Inc. (NASDAQ:DXCM) earned “Buy” rating by Jefferies on Wednesday, February 24.

According to Zacks Investment Research, “Dexcom Inc. is developing continuous glucose monitoring systems for people with diabetes.”

Insitutional Activity: The institutional sentiment increased to 1.35 in Q2 2016. Its up 0.40, from 0.95 in 2016Q1. The ratio is positive, as 30 funds sold all DexCom, Inc. shares owned while 77 reduced positions. 46 funds bought stakes while 98 increased positions. They now own 82.43 million shares or 5.55% more from 78.09 million shares in 2016Q1.
Rothschild Limited Company, a Maryland-based fund reported 66,359 shares. Thompson Davis Company Incorporated has invested 0.01% of its portfolio in DexCom, Inc. (NASDAQ:DXCM). The Illinois-based Ironbridge Cap Mgmt Limited Partnership has invested 0.45% in DexCom, Inc. (NASDAQ:DXCM). Janney Montgomery Scott Ltd Liability Corporation accumulated 5,462 shares or 0.01% of the stock. Wells Fargo Co Mn owns 2.23M shares or 0.07% of their US portfolio. Utd Automobile Association holds 0.01% or 31,699 shares in its portfolio. Next Century Growth Investors last reported 0.18% of its portfolio in the stock. Savant Cap Ltd Liability Company holds 0.93% of its portfolio in DexCom, Inc. (NASDAQ:DXCM) for 41,106 shares. March Altus Cap Mgmt Limited Partnership has 7.17% invested in the company for 11,700 shares. Sectoral Asset Inc holds 3.23% of its portfolio in DexCom, Inc. (NASDAQ:DXCM) for 394,466 shares. Cupps Cap Mgmt Ltd Llc last reported 1.43% of its portfolio in the stock. Paradigm Asset Mngmt Limited accumulated 0% or 9,200 shares. Arrowpoint Asset Mngmt Ltd Com accumulated 432,736 shares or 0.7% of the stock. The Quebec – Canada-based Fiera Capital Corp has invested 0.31% in DexCom, Inc. (NASDAQ:DXCM). Fmr Ltd owns 8.16M shares or 0.09% of their US portfolio.

Insider Transactions: Since April 4, 2016, the stock had 0 buys, and 65 selling transactions for $59.10 million net activity. 3,560 DexCom, Inc. (NASDAQ:DXCM) shares with value of $260,857 were sold by LISTER JOHN. SAYER KEVIN R also sold $559,457 worth of DexCom, Inc. (NASDAQ:DXCM) shares. Pacelli Steven Robert sold $166,190 worth of stock. Shares for $3.39 million were sold by GREGG TERRANCE H on Tuesday, August 9. The insider KAHN BARBARA sold 6,000 shares worth $543,131. 18,038 shares with value of $1.30 million were sold by VALDES JORGE A on Wednesday, June 8. $1.39 million worth of DexCom, Inc. (NASDAQ:DXCM) was sold by MOY JEFFREY on Friday, July 29.

More recent DexCom, Inc. (NASDAQ:DXCM) news were published by: which released: “Reimbursement of Dexcom CGM Technology for Patients with Type 1 and Type 2 …” on September 07, 2016. Also published the news titled: “Dexcom to Expand Manufacturing Operations to Greater Phoenix, Arizona” on June 20, 2016.‘s news article titled: “DexCom Enters Oversold Territory” with publication date: October 03, 2016 was also an interesting one.

DXCM Company Profile

Dexcom, Inc. (Dexcom), incorporated on May 13, 1999, is a medical device company. The Firm is focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers for the treatment of people with and without diabetes. The Company’s products consist of SEVEN PLUS, DexCom G4, DexCom G4 PLATINUM, DexCom Share System and DexCom G5 Mobile. The Firm had received Conformite Europeene Marking (CE Mark) approval for its fourth generation continuous glucose monitoring system, the DexCom G4 system, enabling commercialization of the DexCom G4 system in the European Union, Australia, New Zealand and the countries in Asia and Latin America.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Comment